Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Reduced aldehyde dehydrogenase levels in the brain of patients with Down syndrome
G Lubec, O Labudova, N Cairns, et al.
Amino Acids
|
January 1, 1999
Glycerol affects the quantification of aspartate and glutamate in acid-hydrolyzed proteins
J F Juranville, B Pöschl, G Oesterhelt, et al.
Journal of Interferon Research
|
October 1, 1994
Soluble interferon-gamma receptor: a therapeutically useful drug for systemic lupus erythematosus
L Ozmen, D Roman, M Fountoulakis, et al.
Journal of Neural Transmission. Supplementum
|
January 5, 2002
Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains
S H Kim, M Dierssen, J C Ferreres, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease
B C Yoo, S H Kim, N Cairns, et al.
Proteins
|
December 1, 1995
Crystallization of the complex of human IFN-gamma and the extracellular domain of the IFN-gamma receptor
C Chène, M Fountoulakis, H Döbeli, et al.
Electrophoresis
|
May 27, 1999
Two-dimensional map of human brain proteins
H Langen, P Berndt, D Röder, et al.
The Journal of Biological Chemistry
|
August 5, 1990
Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli
M Fountoulakis, J F Juranville, D Stüber, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
October 8, 2003
Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain
J K Myung, T Gulesserian, M Fountoulakis, et al.
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level
G Lubec, M Nonaka, K Krapfenbauer, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Reduced aldehyde dehydrogenase levels in the brain of patients with Down syndrome
G Lubec, O Labudova, N Cairns, et al.
Amino Acids
|
January 1, 1999
Glycerol affects the quantification of aspartate and glutamate in acid-hydrolyzed proteins
J F Juranville, B Pöschl, G Oesterhelt, et al.
Journal of Interferon Research
|
October 1, 1994
Soluble interferon-gamma receptor: a therapeutically useful drug for systemic lupus erythematosus
L Ozmen, D Roman, M Fountoulakis, et al.
Journal of Neural Transmission. Supplementum
|
January 5, 2002
Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains
S H Kim, M Dierssen, J C Ferreres, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease
B C Yoo, S H Kim, N Cairns, et al.
Proteins
|
December 1, 1995
Crystallization of the complex of human IFN-gamma and the extracellular domain of the IFN-gamma receptor
C Chène, M Fountoulakis, H Döbeli, et al.
Electrophoresis
|
May 27, 1999
Two-dimensional map of human brain proteins
H Langen, P Berndt, D Röder, et al.
The Journal of Biological Chemistry
|
August 5, 1990
Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli
M Fountoulakis, J F Juranville, D Stüber, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
October 8, 2003
Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain
J K Myung, T Gulesserian, M Fountoulakis, et al.
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level
G Lubec, M Nonaka, K Krapfenbauer, et al.
Page
of 12